Dupilumab for maintenance treatment of uncontrolled chronic obstructive pulmonary disease with raised blood eosinophils

  • Technology appraisal guidance
  • TA1142
  • Published: 

Tools and resources

Tools and resources to help you put the guidance into practice.

Resource impact

Implementation support

Guidance into practice